PMCF Study on the Safety and Performance of PROSPACE 3D / PROSPACE 3D OBLIQUE / TSPACE 3D
- Conditions
- Degenerative InstabilityPost-traumatic InstabilitiesSpondylolisthesisPost-discectomy Syndrome
- Registration Number
- NCT04542577
- Lead Sponsor
- Aesculap AG
- Brief Summary
Prospective, pure data collection of all PROSPACE 3D, PROSPACE 3D Oblique, TSPACE 3D patients in selected centers (not interventional, multicenter
- Detailed Description
The study collects a data set for each patient receiving a PROSPACE 3D, PROSPACE 3D Oblique, or TSPACE 3D implant. It is intended to collect data preoperatively, intraoperatively and at one follow-up- assessment after a minimum of one year postoperatively containing
* Basic medical history
* Type of surgical procedure
* Treated segments
* Implant characteristics (including additional implants for anterior/posterior stabilization)
* Scores: ODI, Pain (VAS), EQ-5D
* Patient satisfaction
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 208
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of Spinal Disability measured by Oswestry Disability Index (ODI) preoperatively, at 3 months postoperatively and at 12 months postoperatively The Oswestry Disability Index (ODI) is designed to measure back-specific disability. The questionnaire has 10 items concerning pain and activities of daily living including pain, personal care, lifting, Walking, sitting, standing, sleeping, sex life, social life and travelling. Each question is scored on a scale of 0-5 with the first statement being zero and indicating the least amount of disability and the last statement is scored 5 indicating most severe disability. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.
- Secondary Outcome Measures
Name Time Method Side effects up to 12 months postoperatively Occurrence of complications potentially associated with the implanted devices can never be fully excluded during spinal surgery. In order to monitor potential complication and to identify so far unknown complications AEs and SAEs deemed related to the investigational device are recorded.
Change of Quality of Life (EQ-5D) preoperatively, at 3 months postoperatively and at 12 months postoperatively The score is self-completion by the patient and will therefore be used in German. The Quality of Life Score "EQ-5D" is a standardized 5-dimension 5-level measure of the health status and is developed by the EuroQol Group in order to have a simple and generic measure for clinical and economic assessment. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Change of Pain (VAS) preoperatively, at 3 months postoperatively and at 12 months postoperatively Pain will be assessed by the patient using the Visual Analogue Scale (VAS) which state "0" at one end representing "no pain" and "100" at the opposite end representing "maximal/worst pain"
Bone fusion 12 Months postoperatively After IBF surgery fusion of the treated segment is aspired. Thus, the implant design shall allow on-/ingrowth to/into the material. The fusion status can be determined from radiographs (static or dynamic). Bony fusion can be characterized quantitatively by the fusion rate.
Trial Locations
- Locations (2)
Katholisches Klinikum Koblenz
🇩🇪Koblenz, Germany
Sana Kliniken Sommerfeld
🇩🇪Kremmen, Germany